ZIMMER BIOMET HOLDINGS, INC. Cost of Revenue
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Cost of Revenue of $635.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $635.50M, a 7.31% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $576.20M, a 4.80% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $792.40M, a 35.06% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $559.30M, a 3.84% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for fiscal 2025 was $2.49B, a 13.81% increase from fiscal 2024.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for fiscal 2024 was $2.19B, a 5.15% increase from fiscal 2023.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for fiscal 2023 was $2.08B, a 3.18% increase from fiscal 2022.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods and services sold for fiscal 2022 was $2.02B.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $635.50M 10-Q · filed 2026-08-05 | $1.21B 10-Q · filed 2026-08-05 | $2.00B derived: sum of 3 quarters · filed 2026-08-05 | $2.56B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $576.20M 10-Q · filed 2026-05-01 | $1.37B derived: sum of 2 quarters · filed 2026-05-01 | $1.93B derived: sum of 3 quarters · filed 2026-05-01 | $2.52B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $792.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.35B derived: sum of 2 quarters · filed 2026-02-20 | $1.94B derived: sum of 3 quarters · filed 2026-08-05 | $2.49B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $559.30M 10-Q · filed 2025-11-05 | $1.15B derived: sum of 2 quarters · filed 2026-08-05 | $1.70B 10-Q · filed 2025-11-05 | $2.29B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $592.20M 10-Q · filed 2026-08-05 | $1.14B 10-Q · filed 2026-08-05 | $1.73B derived: sum of 3 quarters · filed 2026-08-05 | $2.27B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $549.80M 10-Q · filed 2026-05-01 | $1.14B derived: sum of 2 quarters · filed 2026-05-01 | $1.68B derived: sum of 3 quarters · filed 2026-05-01 | $2.23B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $586.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.13B derived: sum of 2 quarters · filed 2026-02-20 | $1.68B derived: sum of 3 quarters · filed 2026-02-20 | $2.19B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $538.60M 10-Q · filed 2025-11-05 | $1.09B derived: sum of 2 quarters · filed 2025-11-05 | $1.60B 10-Q · filed 2025-11-05 | $2.14B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $553.60M 10-Q · filed 2025-08-07 | $1.07B 10-Q · filed 2025-08-07 | $1.60B derived: sum of 3 quarters · filed 2026-02-20 | $2.12B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $512.30M 10-Q · filed 2025-05-05 | $1.05B derived: sum of 2 quarters · filed 2026-02-20 | $1.57B derived: sum of 3 quarters · filed 2026-02-20 | $2.10B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $538.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.06B derived: sum of 2 quarters · filed 2026-02-20 | $1.58B derived: sum of 3 quarters · filed 2026-02-20 | $2.08B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $518.60M 10-Q · filed 2024-10-30 | $1.04B derived: sum of 2 quarters · filed 2024-10-30 | $1.54B 10-Q · filed 2024-10-30 | $2.07B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $525.50M 10-Q · filed 2024-08-07 | $1.03B 10-Q · filed 2024-08-07 | $1.55B derived: sum of 3 quarters · filed 2025-02-25 | $2.03B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $500.80M 10-Q · filed 2024-05-02 | $1.02B derived: sum of 2 quarters · filed 2025-02-25 | $1.51B derived: sum of 3 quarters · filed 2025-02-25 | $2.02B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $520.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.01B derived: sum of 2 quarters · filed 2025-02-25 | $1.52B derived: sum of 3 quarters · filed 2025-02-25 | $2.02B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $488.20M 10-Q · filed 2023-11-07 | $999.20M derived: sum of 2 quarters · filed 2023-11-07 | $1.50B 10-Q · filed 2023-11-07 | $2.04B derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-06-30 | $511.00M 10-Q · filed 2023-08-01 | $1.01B 10-Q · filed 2023-08-01 | $1.55B derived: sum of 3 quarters · filed 2024-08-07 | $2.04B derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2022-03-31 | $500.00M 10-Q · filed 2023-05-02 | $1.04B derived: sum of 2 quarters · filed 2024-08-07 | $1.53B derived: sum of 3 quarters · filed 2024-08-07 | $2.02B derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2021-12-31 | $536.50M derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $1.03B derived: sum of 2 quarters · filed 2024-08-07 | $1.52B derived: sum of 3 quarters · filed 2024-08-07 | $1.96B 8-K · filed 2024-08-07 | $2.34B 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $491.40M 10-Q · filed 2022-11-02 | $581.50M 10-Q · filed 2021-11-04 | $987.60M derived: sum of 2 quarters · filed 2022-11-02 | $1.42B 10-Q · filed 2022-11-02 | $1.68B 10-Q · filed 2021-11-04 | $1.77B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | $496.20M 10-Q · filed 2022-08-02 | $581.60M 10-Q · filed 2021-08-03 | $932.50M 10-Q · filed 2022-08-02 | $1.10B 10-Q · filed 2021-08-03 | $1.28B derived: sum of 3 quarters · filed 2023-02-24 | $1.85B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-03-31 | $436.30M 10-Q · filed 2022-05-05 | $516.40M 10-Q · filed 2021-05-04 | $779.60M derived: sum of 2 quarters · filed 2023-02-24 | $1.35B derived: sum of 3 quarters · filed 2023-02-24 | $1.77B derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $343.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $912.70M derived: sum of 2 quarters · filed 2023-02-24 | $1.34B derived: sum of 3 quarters · filed 2023-02-24 | $1.82B 10-K · filed 2023-02-24 | $2.13B 10-K · filed 2021-02-22 | |||
| 2020-09-30 | $569.40M 10-Q · filed 2021-11-04 | $993.90M derived: sum of 2 quarters · filed 2021-11-04 | $1.48B 10-Q · filed 2021-11-04 | $1.75B derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-06-30 | $424.50M 10-Q · filed 2021-08-03 | $911.60M 10-Q · filed 2021-08-03 | $1.18B derived: sum of 3 quarters · filed 2022-06-22 | $1.72B derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2020-03-31 | $487.10M 10-Q · filed 2021-05-04 | $760.40M derived: sum of 2 quarters · filed 2022-06-22 | $1.30B derived: sum of 3 quarters · filed 2022-06-22 | $1.88B derived: sum of 4 quarters · filed 2022-06-22 | ||||
| 2019-12-31 | $273.30M derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $809.00M derived: sum of 2 quarters · filed 2022-06-22 | $1.39B derived: sum of 3 quarters · filed 2022-06-22 | $1.94B 8-K · filed 2022-06-22 | $2.25B 10-K · filed 2020-02-21 | |||
| 2019-09-30 | $535.70M 10-Q · filed 2020-11-06 | $1.12B derived: sum of 2 quarters · filed 2020-11-06 | $1.67B 10-Q · filed 2020-11-06 | $2.25B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $581.30M 10-Q · filed 2020-08-05 | $1.13B 10-Q · filed 2020-08-05 | $1.72B derived: sum of 3 quarters · filed 2021-02-22 | $2.25B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $553.40M 10-Q · filed 2020-05-11 | $1.14B derived: sum of 2 quarters · filed 2021-02-22 | $1.67B derived: sum of 3 quarters · filed 2021-02-22 | $2.25B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $583.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.11B derived: sum of 2 quarters · filed 2021-02-22 | $1.70B derived: sum of 3 quarters · filed 2021-02-22 | $2.27B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $529.00M 10-Q · filed 2019-11-05 | $1.11B derived: sum of 2 quarters · filed 2019-11-05 | $1.69B 10-Q · filed 2019-11-05 | $2.28B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $583.70M 10-Q · filed 2019-08-05 | $1.16B 10-Q · filed 2019-08-05 | $1.75B derived: sum of 3 quarters · filed 2020-02-21 | $2.25B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $575.80M 10-Q · filed 2019-05-06 | $1.17B derived: sum of 2 quarters · filed 2020-02-21 | $1.67B derived: sum of 3 quarters · filed 2020-02-21 | |||||
| 2017-12-31 | $591.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $1.09B derived: sum of 2 quarters · filed 2020-02-21 | $2.13B 10-K · filed 2020-02-21 | |||||
| 2017-09-30 | $500.90M 10-Q · filed 2018-11-01 | $1.54B 10-Q · filed 2018-11-01 | ||||||
| 2016-12-31 | $2.38B 10-K · filed 2019-02-26 | |||||||
| 2011-03-31 | $279.00M 10-Q · filed 2011-05-05 | $553.20M derived: sum of 2 quarters · filed 2011-05-05 | $772.40M derived: sum of 3 quarters · filed 2011-05-05 | $1.02B derived: sum of 4 quarters · filed 2011-05-05 | ||||
| 2010-12-31 | $274.20M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $493.40M derived: sum of 2 quarters · filed 2011-02-25 | $744.00M derived: sum of 3 quarters · filed 2011-02-25 | $1.01B 10-K · filed 2011-02-25 | ||||
| 2010-09-30 | $219.20M 10-Q · filed 2010-11-03 | $469.80M derived: sum of 2 quarters · filed 2010-11-03 | $738.20M 10-Q · filed 2010-11-03 | $1.01B derived: sum of 4 quarters · filed 2011-05-05 | ||||
| 2010-06-30 | $250.60M 10-Q · filed 2010-08-05 | $519.00M 10-Q · filed 2010-08-05 | $793.40M derived: sum of 3 quarters · filed 2011-05-05 | $1.04B derived: sum of 4 quarters · filed 2011-05-05 | ||||
| 2010-03-31 | $268.40M 10-Q · filed 2011-05-05 | $542.80M derived: sum of 2 quarters · filed 2011-05-05 | $792.10M derived: sum of 3 quarters · filed 2011-05-05 | $1.03B derived: sum of 4 quarters · filed 2011-05-05 | ||||
| 2009-12-31 | $274.40M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $523.70M derived: sum of 2 quarters · filed 2011-02-25 | $760.50M derived: sum of 3 quarters · filed 2011-02-25 | $990.70M 10-K · filed 2011-02-25 | $990.80M 10-K · filed 2010-02-25 | |||
| 2009-09-30 | $249.30M 10-Q · filed 2010-11-03 | $486.10M derived: sum of 2 quarters · filed 2010-11-03 | $716.30M 10-Q · filed 2010-11-03 | $716.40M 10-Q · filed 2009-11-04 | $959.40M derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-06-30 | $236.80M 10-Q · filed 2010-08-05 | $467.00M 10-Q · filed 2010-08-05 | $467.10M 10-Q/A · filed 2009-08-17 | $710.10M derived: sum of 3 quarters · filed 2011-02-25 | $947.30M derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-03-31 | $230.20M 10-Q · filed 2010-05-05 | $473.30M derived: sum of 2 quarters · filed 2011-02-25 | $710.50M derived: sum of 3 quarters · filed 2011-02-25 | $972.80M derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-31 | $243.10M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $480.30M derived: sum of 2 quarters · filed 2011-02-25 | $742.60M derived: sum of 3 quarters · filed 2011-02-25 | $997.30M 10-K · filed 2011-02-25 | ||||
| 2008-09-30 | $237.20M 10-Q · filed 2009-11-04 | $499.50M derived: sum of 2 quarters · filed 2009-11-04 | $754.20M 10-Q · filed 2009-11-04 | |||||
| 2008-06-30 | $262.30M 10-Q/A · filed 2009-08-17 | $517.00M 10-Q/A · filed 2009-08-17 | ||||||
| 2007-12-31 | $875.90M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |